Phase I trial of ELND 005 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2010
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Transition Therapeutics
- 30 Aug 2007 Status change from initiated to completed
- 14 Aug 2007 New trial record.